Back
ESC Premium Access

Increased dose of diuretics correlates with severity of heart failure and renal dysfunction and does not lead to reduction of mortality and rehospitalizations, data from AHEAD registry

Session: Poster Session 7 - Chronic heart failure – Treatment
Topic: Pharmacotherapy
Speaker: Doctor M. Miklikova (Brno, CZ)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Marie Miklikova

FNUSA, Brno (Czechia)
0 follower

8 more presentations in this session

Hemodynamic evaluation of patients with advanced heart failure receiving ambulatory intermittent cycles of levosimendan as bridge to transplant

Speaker: Doctor I. Hernandez Gonzalez (Valladolid, ES)

Access
Abstract
Like
Thumbnail

Cardiorenal protection by subcutaneous cenderitide in experimental heart failure: a novel and safe therapeutic for humans with LVAD support

Speaker: Doctor T. Ichiki (Rochester, US)

Access
Abstract
Like
Thumbnail

Identification of patients eligible to start sacubitril valsartan in a stable heart failure population

Speaker: Doctor S. Aktaa (Leeds, GB)

Access
Abstract
Slides
Like
Thumbnail

What proportion of patients with heart failure are candidates for sacubitril/valsartan? Differences between guideline recommendations and regulatory labels

Speaker: Doctor P. Pellicori (Glasgow, GB)

Access
Abstract
Like
Thumbnail

Initiation of sacubitril/valsartan in hospitalized patients with HFrEF after hemodynamic stabilization: baseline characteristics of the TRANSITION study compared with TITRATION and PARADIGM-HF

Speaker: Doctor M. Senni (Bergamo, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 7 - Chronic heart failure – Treatment

Speakers: Doctor M. Miklikova, Doctor I. Hernandez Gonzalez, Doctor T. Ichiki, Doctor S. Aktaa, Doctor P. Pellicori...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources